Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mairs & Power Growth Fund Investor Class (MPGFX)

Net Asset Value
1 Day
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks to provide shareholders with a diversified portfolio of common stocks- which have the potential for above-average- long-term appreciation. The fund invests primarily in U.S. common stocks. It may also invest in securities of foreign issuers which are listed on a U.S. stock exchange or are represented by American Depositary Receipts. In selecting securities for the fund- its investment adviser gives preference to holdings in high quality companies- which are characterized by earnings that are reasonably predictable- have a return on equity that is above-average- hold market dominance and have financial strength.


1 month+3.39% 3 years+9.17%
3 months+8.39% 5 years+13.86%
1 year+13.73% Since inception+11.41%
Data through --

Peer Comparisonvs. Large blend

Performance 5-yr return+13.86%+12.91%
Expense ratio0.66%0.98%
Risk 5 year sharpe ratio1.301.37
Net assets$4.8B$5.3B
Average market cap$30.1B$132.8B
Average P/E24.522.2
Portfolio turnover11%11%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyMairs & Power
Fund manager & tenureMark Henneman / 11 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00


U.S. stock95.32%
International stock2.79%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 41.65%
Healthcare 18.38%
Financial service 12.97%
Business service 8.08%
Consumer goods 6.82%
Top 10 Holdings
Portfolio weighting
ECL Ecolab Inc4.81%
USB U.S. Bancorp4.78%
HON Honeywell4.23%
GGG Graco Inc3.97%
MMM 3M3.81%
JNJ Johnson & Johnson3.64%
MDT Medtronic PLC3.56%
DCI Donaldson Company Inc3.38%
ABT Abbott Laboratories3.33%
HRL Hormel Foods Corp2.95%